XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
American Biogenetic Sciences, Inc. - Balance Sheets (USD $)
Dec. 31, 2014
Dec. 31, 2013
Balance Sheets    
Cash $ 0us-gaap_Cash $ 0us-gaap_Cash
Total current assets 0us-gaap_AssetsCurrent 0us-gaap_AssetsCurrent
Total Assets 0us-gaap_Assets 0us-gaap_Assets
Accounts payable - trade 12,800us-gaap_AccountsPayableTradeCurrent 2,250us-gaap_AccountsPayableTradeCurrent
Accrued interest expenses 50,310fil_AccruedInterestExpenses 38,760fil_AccruedInterestExpenses
Convertible note, related party 331,681fil_ConvertibleNoteRelatedParty 331,681fil_ConvertibleNoteRelatedParty
Advances from and accruals due to related party 18,375fil_AdvancesFromAndAccrualsDueToRelatedParty 0fil_AdvancesFromAndAccrualsDueToRelatedParty
Total current liabilities 413,166us-gaap_LiabilitiesCurrent 372,691us-gaap_LiabilitiesCurrent
Total liabilities 413,166us-gaap_Liabilities 372,691us-gaap_Liabilities
Preferred stock    [1]    [1]
Common stock 109us-gaap_CommonStockValue [2] 109us-gaap_CommonStockValue [2]
Additional paid in capital 46,191us-gaap_AdditionalPaidInCapital 46,191us-gaap_AdditionalPaidInCapital
Accumulated deficit (459,466)us-gaap_RetainedEarningsAccumulatedDeficit (418,991)us-gaap_RetainedEarningsAccumulatedDeficit
Total Stockholders' Deficiency (413,166)us-gaap_StockholdersEquity (372,691)us-gaap_StockholdersEquity
Total Liabilities and Stockholders' Deficiency $ 0us-gaap_LiabilitiesAndStockholdersEquity $ 0us-gaap_LiabilitiesAndStockholdersEquity
[1] $0.0001 par value; 10,000,000 shares authorized; none issued
[2] $0.0001 par value; 100,000,000 shares authorized; 1,088,740 issued and outstanding at December 31, 2014 and 2013